Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Free Cash Flow (2018 - 2025)

Avai Bio's Free Cash Flow history spans 6 years, with the latest figure at -$136522.0 for Q1 2024.

  • On a quarterly basis, Free Cash Flow fell 85.76% to -$136522.0 in Q1 2024 year-over-year; TTM through Mar 2024 was -$1.3 million, a 2328.19% decrease, with the full-year FY2025 number at -$1.2 million, up 12.23% from a year prior.
  • Free Cash Flow hit -$136522.0 in Q1 2024 for Avai Bio, up from -$705669.0 in the prior quarter.
  • Over the last five years, Free Cash Flow for AVAI hit a ceiling of $109582.0 in Q1 2020 and a floor of -$705669.0 in Q4 2023.
  • Historically, Free Cash Flow has averaged -$117843.8 across 4 years, with a median of -$66609.5 in 2023.
  • Biggest five-year swings in Free Cash Flow: surged 489.87% in 2020 and later tumbled 2265.56% in 2023.
  • Tracing AVAI's Free Cash Flow over 4 years: stood at -$122550.0 in 2020, then skyrocketed by 126.59% to $32586.0 in 2022, then tumbled by 2265.56% to -$705669.0 in 2023, then skyrocketed by 80.65% to -$136522.0 in 2024.
  • Business Quant data shows Free Cash Flow for AVAI at -$136522.0 in Q1 2024, -$705669.0 in Q4 2023, and -$420401.0 in Q3 2023.